Qiang Hu

246 Xuefu Road
Harbin, 150086, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

STAT1/SLC31A1 signaling promotes diabetic retinopathy progression by mediating cuproptosis-induced M1 polarization in microglial cells.

STAT1/SLC31A1 signaling promotes diabetic retinopathy progression by mediating cuproptosis-induced M1 polarization in microglial cells.

Journal: Life sciences
Published: June 24, 2025

Methyltransferase-like 14 suppresses the retinal neovascularization by reducing HIF-1α in proliferative retinopathy.

Methyltransferase-like 14 suppresses the retinal neovascularization by reducing HIF-1α in proliferative retinopathy.

Journal: European journal of medical research
Published: March 27, 2025

METTL14-dependent regulation of HMGB1 attenuates inflammation in diabetic retinopathy.

METTL14-dependent regulation of HMGB1 attenuates inflammation in diabetic retinopathy.

Journal: Acta diabetologica
Published: March 01, 2025

Inhibition of Dectin-1 alleviates inflammation in early diabetic retinopathy by regulating microglia phenotype.

Inhibition of Dectin-1 alleviates inflammation in early diabetic retinopathy by regulating microglia phenotype.

Journal: Gene
Published: February 17, 2025

Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration.

Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration.

Journal: Journal of inflammation research
Published: October 10, 2024

Epigallocatechin gallate ameliorates retinal pigment epithelial cell damage via the CYFIP2 /AKT pathway.

Epigallocatechin gallate ameliorates retinal pigment epithelial cell damage via the CYFIP2 /AKT pathway.

Journal: Toxicology and applied pharmacology
Published: June 25, 2024

The STAT1-SLC31A1 axis: Potential regulation of cuproptosis in diabetic retinopathy.

The STAT1-SLC31A1 axis: Potential regulation of cuproptosis in diabetic retinopathy.

Journal: Gene
Published: May 13, 2024

Therapeutic potential of flavopiridol in diabetic retinopathy: Targeting DDX58.

Therapeutic potential of flavopiridol in diabetic retinopathy: Targeting DDX58.

Journal: International immunopharmacology
Published: April 25, 2024

A New Modulator of Neuroinflammation in Diabetic Retinopathy: USP25.

A New Modulator of Neuroinflammation in Diabetic Retinopathy: USP25.

Journal: Inflammation
Published: December 31, 2023

Bioinformatics analysis for constructing a cellular senescence-related age-related macular degeneration diagnostic model and identifying relevant disease subtypes to guide treatment.

Bioinformatics analysis for constructing a cellular senescence-related age-related macular degeneration diagnostic model and identifying relevant disease subtypes to guide treatment.

Journal: Aging
Published: November 07, 2023

Role of Interleukin-21 in retinal ischemia-reperfusion injury: Unveiling the impact on retinal ganglion cell apoptosis.

Role of Interleukin-21 in retinal ischemia-reperfusion injury: Unveiling the impact on retinal ganglion cell apoptosis.

Journal: International immunopharmacology
Published: October 23, 2023

Potential epigenetic molecular regulatory networks in ocular neovascularization.

Potential epigenetic molecular regulatory networks in ocular neovascularization.

Journal: Frontiers in genetics
Published: June 20, 2022
Showing 1-12 of 12

Last Updated: 09/26/2026